In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) closed at $8.33 in the last session, up 0.60% from day before closing price of $8.28. In other words, the price has increased by $0.60 from its previous closing price. On the day, 1.41 million shares were traded. AUPH stock price reached its highest trading level at $8.41 during the session, while it also had its lowest trading level at $8.1011.
Ratios:
We take a closer look at AUPH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.47. For the most recent quarter (mrq), Quick Ratio is recorded 5.11 and its Current Ratio is at 5.60. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.19.
Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 11 ’24 when Bailey Jeffrey Allen sold 4,557 shares for $8.43 per share. The transaction valued at 38,416 led to the insider holds 13,356 shares of the business.
Smith Karen L. sold 5,241 shares of AUPH for $44,182 on Nov 11 ’24. The Director now owns 12,672 shares after completing the transaction at $8.43 per share. On Aug 06 ’24, another insider, Habig Scott Michael, who serves as the Chief Commercial Officer of the company, sold 18,249 shares for $5.31 each. As a result, the insider received 96,902 and left with 456,338 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUPH now has a Market Capitalization of 1192681088 and an Enterprise Value of 932299328. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.41 while its Price-to-Book (P/B) ratio in mrq is 3.07. Its current Enterprise Value per Revenue stands at 4.231 whereas that against EBITDA is 1883.433.
Stock Price History:
Over the past 52 weeks, AUPH has reached a high of $10.05, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is 14.93%, while the 200-Day Moving Average is calculated to be 37.22%.
Shares Statistics:
According to the various share statistics, AUPH traded on average about 1.26M shares per day over the past 3-months and 1702390 shares per day over the past 10 days. A total of 143.83M shares are outstanding, with a floating share count of 128.85M. Insiders hold about 10.01% of the company’s shares, while institutions hold 39.97% stake in the company. Shares short for AUPH as of 1730332800 were 7344712 with a Short Ratio of 5.81, compared to 1727654400 on 7238554. Therefore, it implies a Short% of Shares Outstanding of 7344712 and a Short% of Float of 5.1599998000000005.
